Reuters: Regulatory News: Wockhardt's Q2 profit more than halves, hit by export curbs

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

The Best Way to Manage your Money. Start using Mint today to set a budget, track your goals and do more with your money. From our sponsors

Wockhardt's Q2 profit more than halves, hit by export curbs Oct 25th 2013, 08:11 Fri Oct 25, 2013 4:11am EDT Oct 25 (Reuters) - Indian drugmaker Wockhardt Ltd reported a 69 percent fall in quarterly profit, hit by curbs on shipping medicines to the United States and Britain from one of its plants after their health regulators identified quality deficiencies. Wockhardt posted a net profit of 1.4 billion rupees ($23 million) for the three months ended Sept. 30, compared with 4.5 billion rupees a year ago. Revenues fell 11 percent to 12 billion rupees, the company said in a statement on Friday. The average estimate for the company's net profit was 2.4 billion rupees, according to a Reuters poll of two brokerages. Wockhardt has previously said the U.S. ban on the Waluj factory in western India, reported in May, could cost the company about $100 million in sales a year. The United States and Europe accounted for three-quarters of the company's revenues in the last fiscal year that ended in March.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions